newsfilter
← Latest News
Business Wire·

Ambrx Appoints Sonja Nelson as Chief Financial Officer

​Ambrx (NYSE:AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, today announced the appointment of Sonja Nelson to Chief Financial Officer. "I am delighted